VERTEX PHARMACEUTICALS INC / MA Restructuring Charges
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Restructuring Charges of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-02-11
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for the quarter ending 2019-12-31 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for the quarter ending 2019-06-30 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for fiscal 2020 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for fiscal 2019 was $0.00.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for fiscal 2018 was -$184.00K, a 101.29% decline from fiscal 2017.
- VERTEX PHARMACEUTICALS INC / MA restructuring charges for fiscal 2017 was $14.25M, a 1028.84% increase from fiscal 2016.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 84 month | Restructuring Charges 96 month | Restructuring Charges 108 month |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-11 | |||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $0.00 derived: sum of 3 quarters · filed 2021-02-11 | $0.00 10-K · filed 2021-02-11 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | -$4.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | -$4.00K derived: sum of 3 quarters · filed 2020-02-13 | $170.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | -$4.00K derived: sum of 2 quarters · filed 2020-02-13 | $170.00K derived: sum of 3 quarters · filed 2020-02-13 | $108.00K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-12-31 | -$4.00K 10-K · filed 2020-02-13 | $4.00K 10-K · filed 2019-02-13 | $170.00K derived: sum of 2 quarters · filed 2020-02-13 | $108.00K derived: sum of 3 quarters · filed 2020-02-13 | -$184.00K 10-K · filed 2021-02-11 | |||
| 2018-09-30 | $174.00K 10-K · filed 2020-02-13 | -$174.00K 10-Q · filed 2018-10-25 | $112.00K derived: sum of 2 quarters · filed 2020-02-13 | -$188.00K 10-Q · filed 2019-10-31 | $575.00K derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | -$62.00K 10-K · filed 2020-02-13 | $62.00K 10-Q · filed 2018-07-26 | -$14.00K 10-Q · filed 2019-08-01 | $401.00K derived: sum of 3 quarters · filed 2020-02-13 | $738.00K derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $76.00K 10-K · filed 2020-02-13 | -$76.00K 10-Q · filed 2018-04-27 | $463.00K derived: sum of 2 quarters · filed 2020-02-13 | $800.00K derived: sum of 3 quarters · filed 2020-02-13 | $4.32M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $387.00K 10-K · filed 2019-02-13 | $724.00K derived: sum of 2 quarters · filed 2019-02-13 | $4.25M derived: sum of 3 quarters · filed 2019-02-13 | $14.25M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | $337.00K 10-K · filed 2019-02-13 | $3.86M derived: sum of 2 quarters · filed 2019-02-13 | $13.86M 10-Q · filed 2018-10-25 | $14.08M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $3.52M 10-K · filed 2019-02-13 | $13.52M 10-Q · filed 2018-07-26 | $13.75M derived: sum of 3 quarters · filed 2019-02-13 | $13.75M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $10.00M 10-K · filed 2019-02-13 | $10.22M derived: sum of 2 quarters · filed 2019-02-13 | $10.23M derived: sum of 3 quarters · filed 2019-02-13 | $10.57M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $224.00K 10-K · filed 2018-02-15 | $232.00K derived: sum of 2 quarters · filed 2018-02-15 | $575.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.26M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | $8.00K 10-K · filed 2018-02-15 | $351.00K derived: sum of 2 quarters · filed 2018-02-15 | $1.04M 10-Q · filed 2017-10-30 | $2.56M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $343.00K 10-K · filed 2018-02-15 | $1.03M 10-Q · filed 2017-07-28 | $2.55M derived: sum of 3 quarters · filed 2018-02-15 | $4.38M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $687.00K 10-K · filed 2018-02-15 | $2.21M derived: sum of 2 quarters · filed 2018-02-15 | $4.04M derived: sum of 3 quarters · filed 2018-02-15 | $6.17M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $1.52M 10-K · filed 2017-02-23 | $3.35M derived: sum of 2 quarters · filed 2017-02-23 | $5.48M derived: sum of 3 quarters · filed 2017-02-23 | $2.21M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $1.83M 10-K · filed 2017-02-23 | $3.95M derived: sum of 2 quarters · filed 2017-02-23 | $682.00K 10-Q · filed 2016-10-31 | $4.85M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $2.13M 10-K · filed 2017-02-23 | -$1.14M 10-Q · filed 2016-08-01 | $3.02M derived: sum of 3 quarters · filed 2017-02-23 | $43.86M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$3.27M 10-K · filed 2017-02-23 | $892.00K derived: sum of 2 quarters · filed 2017-02-23 | $41.73M derived: sum of 3 quarters · filed 2017-02-23 | $41.47M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $4.16M 10-K · filed 2016-02-16 | $45.01M derived: sum of 2 quarters · filed 2016-02-16 | $44.74M derived: sum of 3 quarters · filed 2016-02-16 | $50.92M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $40.84M 10-K · filed 2016-02-16 | $40.57M derived: sum of 2 quarters · filed 2016-02-16 | $46.76M 10-Q · filed 2015-10-30 | $74.42M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$270.00K 10-K · filed 2016-02-16 | $5.92M 10-Q · filed 2015-08-04 | $33.58M derived: sum of 3 quarters · filed 2016-02-16 | $45.62M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $6.19M 10-K · filed 2016-02-16 | $33.85M derived: sum of 2 quarters · filed 2016-02-16 | $45.89M derived: sum of 3 quarters · filed 2016-02-16 | $46.67M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $27.66M 10-K · filed 2015-02-13 | $39.71M derived: sum of 2 quarters · filed 2015-02-13 | $40.48M derived: sum of 3 quarters · filed 2015-02-13 | $40.52M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $12.05M 10-K · filed 2015-02-13 | $12.82M derived: sum of 2 quarters · filed 2015-02-13 | $12.86M 10-Q · filed 2014-11-06 | $13.06M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | $776.00K 10-K · filed 2015-02-13 | $815.00K 10-Q · filed 2014-07-31 | $1.01M derived: sum of 3 quarters · filed 2015-02-13 | $1.71M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | $39.00K 10-K · filed 2015-02-13 | $233.00K derived: sum of 2 quarters · filed 2015-02-13 | $929.00K derived: sum of 3 quarters · filed 2015-02-13 | $1.52M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $194.00K 10-K · filed 2014-02-11 | $890.00K derived: sum of 2 quarters · filed 2014-02-11 | $1.48M derived: sum of 3 quarters · filed 2014-02-11 | $1.84M 10-K · filed 2015-02-13 | $62.48M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | $696.00K 10-K · filed 2014-02-11 | $1.29M derived: sum of 2 quarters · filed 2014-02-11 | $1.65M 10-Q · filed 2013-11-07 | $2.64M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $594.00K 10-K · filed 2014-02-11 | $954.00K 10-Q · filed 2013-08-02 | $1.95M derived: sum of 3 quarters · filed 2014-02-11 | $1.53M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $360.00K 10-K · filed 2014-02-11 | $1.35M derived: sum of 2 quarters · filed 2014-02-11 | $933.00K derived: sum of 3 quarters · filed 2014-02-11 | $1.67M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $992.00K 10-K · filed 2013-03-01 | $573.00K derived: sum of 2 quarters · filed 2013-03-01 | $1.31M derived: sum of 3 quarters · filed 2013-03-01 | $2.07M 10-K · filed 2014-02-11 | $60.63M 10-K · filed 2012-02-22 | |||
| 2011-09-30 | -$419.00K 10-K · filed 2013-03-01 | $322.00K derived: sum of 2 quarters · filed 2013-03-01 | $1.08M 10-Q · filed 2012-11-06 | -$1.18M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $741.00K 10-K · filed 2013-03-01 | $1.50M 10-Q · filed 2012-08-08 | -$756.00K derived: sum of 3 quarters · filed 2013-03-01 | $110.00K derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $760.00K 10-K · filed 2013-03-01 | -$1.50M derived: sum of 2 quarters · filed 2013-03-01 | -$631.00K derived: sum of 3 quarters · filed 2013-03-01 | $1.48M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | -$2.26M 10-K · filed 2012-02-22 | -$1.39M derived: sum of 2 quarters · filed 2012-02-22 | $721.00K derived: sum of 3 quarters · filed 2012-02-22 | $1.50M 10-K · filed 2013-03-01 | $58.56M 10-K · filed 2011-02-17 | |||
| 2010-09-30 | $866.00K 10-K · filed 2012-02-22 | $2.98M derived: sum of 2 quarters · filed 2012-02-22 | $3.76M 10-Q · filed 2011-11-03 | $5.71M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $2.11M 10-K · filed 2012-02-22 | $2.89M 10-Q · filed 2011-08-09 | $4.85M derived: sum of 3 quarters · filed 2012-02-22 | $5.62M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $780.00K 10-K · filed 2012-02-22 | $2.74M derived: sum of 2 quarters · filed 2012-02-22 | $3.51M derived: sum of 3 quarters · filed 2012-02-22 | $4.62M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $1.96M 10-K · filed 2011-02-17 | $2.73M derived: sum of 2 quarters · filed 2011-02-17 | $3.84M derived: sum of 3 quarters · filed 2011-02-17 | $6.24M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $774.00K 10-K · filed 2011-02-17 | $1.88M derived: sum of 2 quarters · filed 2011-02-17 | $4.28M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $1.11M 10-K · filed 2011-02-17 | $3.51M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $2.40M 10-K · filed 2011-02-17 | |||||||
| 2008-12-31 | $4.32M 10-K · filed 2011-02-17 | |||||||
| 2003-12-31 | $91.82M 10-K · filed 2015-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |